Patents by Inventor Weiyuan Wang
Weiyuan Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11944677Abstract: This invention relates to chimeric virus-like particles (VLPs) assembled from a polypeptide comprising a papilloma virus (PV) L1 protein or L1/L2 protein and a target peptide comprising a CD8+ T cell epitope derived from a human pathogen. This invention also relates to methods using the chimeric VLPs as antigen-specific redirectors of immune responses.Type: GrantFiled: March 25, 2022Date of Patent: April 2, 2024Assignee: VERIMMUNE INC.Inventors: Joshua Weiyuan Wang, Nattha Ingavat
-
Patent number: 11858964Abstract: Disclosed are virus-inspired compositions and preparation methods thereof, where the compositions comprise mutant papillomavirus L1 proteins that spontaneously form capsid backbones and that are conjugated to a peptide comprising an epitope to form immune redirector capsids (IRCs). The epitopes on the peptides are designed to be recognized by a subject's immune system based on the subject's preexisting immune memory developed from the subject's past exposure to the epitope through infection or vaccination. The mutant papillomavirus L1 proteins possess three mutations including an amino-terminal truncation, a carboxy-terminal truncation, and a truncation at helix four. These mutations in the L1 protein yield capsomeres that are form non-canonical T=1 geometry capsid backbones. Disclosed are uses and methods of using the compositions in treating and/or preventing cancers in subjects in need thereof.Type: GrantFiled: October 19, 2021Date of Patent: January 2, 2024Assignee: VerImmune Inc.Inventors: Joshua Weiyuan Wang, Ken Matsui, Philip Alan Storm, Kristin Marie Peters
-
Publication number: 20230391830Abstract: Disclosed is a new class of conjugated virus-like particles (VLPs). These conjugated VLPs bind a wide variety of tumors and comprise epitopes recognized by a prior T cell immune response already existing in a host. These epitopes are derived from pathogens or previous vaccinations (such as early childhood vaccines). This provokes the body's pre-existing cytotoxic immunity obtained through previous infection or previous childhood vaccination to be redirected to the tumor cells for the elimination of cancer, and form long-term anti-tumor immunity. The described conjugated VLPs are useful for tailoring a broad range of tumors towards a response from existing immunity circumventing the need to identify tumor antigens or generate tumor-specific immune responses.Type: ApplicationFiled: August 15, 2022Publication date: December 7, 2023Inventors: Joshua Weiyuan WANG, Nattha INGAVAT, Ken MATSUI
-
Patent number: 11833370Abstract: A method for irradiation based on a fluence map includes determining a shield type of each row of a fluence map. The method also includes determining, for each of the two rows, a movement curve indicating a relationship between an irradiation dose in the each of the two rows and a moving position of a leaf pair corresponding to the each of the two rows. The method further includes determining an initial irradiation dose for each of the movement curves and synchronizing one of the movement curves based on the shield types of the two rows. The method also includes selecting at least one irradiation dose of at least one point on an irradiation dose axis and generating a control point according to the selected irradiation dose.Type: GrantFiled: August 30, 2021Date of Patent: December 5, 2023Assignee: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventor: Weiyuan Wang
-
Publication number: 20230069291Abstract: The disclosure provides systems and methods for generating a treatment plan for irradiating a target region. The system may obtain at least one parameter from the treatment plan. The at least one parameter may relate to a dose region where is enclosed by an isodose curve. The system may obtain an objective function corresponding to the target region. The objective function may represent a conformity between the target region and the dose region. The system may further generate the treatment plan by optimizing the at least one parameter such that the objective function satisfies an optimization condition.Type: ApplicationFiled: August 25, 2022Publication date: March 2, 2023Applicant: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventors: Junxiang TANG, Weiyuan WANG
-
Patent number: 11571590Abstract: The present disclosure provides a radiation method for radiating a fluence map having a zero-fluence region under a movement of MLC (Multi-Leaf Collimator) includes a determining step of determining at least one basic fluence map from the fluence map. The basic fluence map includes a first non-zero fluence region and a second non-fluence region having the zero-fluence region therebetween. The radiation method includes a first radiating step including radiating the first non-zero fluence region, along with moving a first group of leaf pairs and moving a vertical jaw to shade the first group of leaf pairs, and a second radiating step including radiating the second non-zero fluence region, along with moving a second group of leaf pairs and withdrawing the vertical jaw to expose the second group of leaf pairs.Type: GrantFiled: December 31, 2020Date of Patent: February 7, 2023Assignee: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventor: Weiyuan Wang
-
Patent number: 11560408Abstract: Disclosed is a new class of conjugated virus-like particles (VLPs). These conjugated VLPs bind a wide variety of tumors and comprise epitopes recognized by a prior T cell immune response already existing in a host. These epitopes are derived from pathogens or previous vaccinations (such as early childhood vaccines). This provokes the body's pre-existing cytotoxic immunity obtained through previous infection or previous childhood vaccination to be redirected to the tumor cells for the elimination of cancer, and form long-term anti-tumor immunity. The described conjugated VLPs are useful for tailoring a broad range of tumors towards a response from existing immunity circumventing the need to identify tumor antigens or generate tumor-specific immune responses.Type: GrantFiled: December 26, 2019Date of Patent: January 24, 2023Assignee: VERIMMUNE INC.Inventors: Joshua Weiyuan Wang, Nattha Ingavat, Ken Matsui
-
Publication number: 20220401057Abstract: A radiographic phantom comprises: a body comprising a wax material or a wax-like material, wherein the body has an x-ray attenuation value that is approximately the same as that of a human tissue; and a plurality of crystalline test objects positioned on or within the body. A method comprises: obtaining a radiographic phantom comprising a body and a plurality of crystalline test objects positioned on or within the body, wherein the body comprises a wax material or a wax-like material, and wherein the body has an x-ray attenuation value that is approximately the same as that of a human breast tissue; performing an operation of the radiographic phantom and using a device; and assessing a performance of the device based on the operation.Type: ApplicationFiled: June 14, 2022Publication date: December 22, 2022Inventors: Dee H. Wu, Elizabeth A. Jett, Natalie Stratemeier, Hong Liu, Caroline J. Preskitt, Weiyuan Wang, Min Yang
-
Publication number: 20220226460Abstract: This invention relates to chimeric virus-like particles (VLPs) assembled from a polypeptide comprising a papilloma virus (PV) L1 protein or L1/L2 protein and a target peptide comprising a CD8+ T cell epitope derived from a human pathogen. This invention also relates to methods using the chimeric VLPs as antigen-specific redirectors of immune responses.Type: ApplicationFiled: March 25, 2022Publication date: July 21, 2022Inventors: Joshua Weiyuan WANG, Nattha INGAVAT
-
Publication number: 20220135624Abstract: Disclosed are virus-inspired compositions and preparation methods thereof, where the compositions comprise mutant papillomavirus L1 proteins that spontaneously form capsid backbones and that are conjugated to a peptide comprising an epitope to form immune redirector capsids (IRCs). The epitopes on the peptides are designed to be recognized by a subject's immune system based on the subject's preexisting immune memory developed from the subject's past exposure to the epitope through infection or vaccination. The mutant papillomavirus L1 proteins possess three mutations including an amino-terminal truncation, a carboxy-terminal truncation, and a truncation at helix four. These mutations in the L1 protein yield capsomeres that are form non-canonical T=1 geometry capsid backbones. Disclosed are uses and methods of using the compositions in treating and/or preventing cancers in subjects in need thereof.Type: ApplicationFiled: October 19, 2021Publication date: May 5, 2022Inventors: Joshua Weiyuan WANG, Ken MATSUI, Philip Alan STORM, Kristin Marie PETERS
-
Patent number: 11285203Abstract: This invention relates to chimeric virus-like particles (VLPs) assembled from a polypeptide comprising a papilloma virus (PV) L1 protein or L1/L2 protein and a target peptide comprising a CD8+ T cell epitope derived from a human pathogen. This invention also relates to methods using the chimeric VLPs as antigen-specific redirectors of immune responses.Type: GrantFiled: June 21, 2018Date of Patent: March 29, 2022Assignee: VERIMMUNE INC.Inventors: Joshua Weiyuan Wang, Nattha Ingavat
-
Publication number: 20210387019Abstract: A method for irradiation based on a fluence map includes determining a shield type of each row of a fluence map. The method also includes determining, for each of the two rows, a movement curve indicating a relationship between an irradiation dose in the each of the two rows and a moving position of a leaf pair corresponding to the each of the two rows. The method further includes determining an initial irradiation dose for each of the movement curves and synchronizing one of the movement curves based on the shield types of the two rows. The method also includes selecting at least one irradiation dose of at least one point on an irradiation dose axis and generating a control point according to the selected irradiation dose.Type: ApplicationFiled: August 30, 2021Publication date: December 16, 2021Applicant: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventor: Weiyuan WANG
-
Patent number: 11103728Abstract: A method for irradiation based on a fluence map includes determining a shield type of each row of a fluence map. The method also includes determining, for each of the two rows, a movement curve indicating a relationship between an irradiation dose in the each of the two rows and a moving position of a leaf pair corresponding to the each of the two rows. The method further includes determining an initial irradiation dose for each of the movement curves and synchronizing one of the movement curves based on the shield types of the two rows. The method also includes selecting at least one irradiation dose of at least one point on an irradiation dose axis and generating a control point according to the selected irradiation dose.Type: GrantFiled: September 30, 2019Date of Patent: August 31, 2021Assignee: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventor: Weiyuan Wang
-
Publication number: 20210121714Abstract: The present disclosure provides a radiation method for radiating a fluence map having a zero-fluence region under a movement of MLC (Multi-Leaf Collimator) includes a determining step of determining at least one basic fluence map from the fluence map. The basic fluence map includes a first non-zero fluence region and a second non-fluence region having the zero-fluence region therebetween. The radiation method includes a first radiating step including radiating the first non-zero fluence region, along with moving a first group of leaf pairs and moving a vertical jaw to shade the first group of leaf pairs, and a second radiating step including radiating the second non-zero fluence region, along with moving a second group of leaf pairs and withdrawing the vertical jaw to expose the second group of leaf pairs.Type: ApplicationFiled: December 31, 2020Publication date: April 29, 2021Applicant: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventor: Weiyuan WANG
-
Patent number: 10881876Abstract: The present disclosure provides a radiation method for radiating a fluence map having a zero-fluence region under a movement of MLC (Multi-Leaf Collimator) includes a determining step of determining at least one basic fluence map from the fluence map. The basic fluence map includes a first non-zero fluence region and a second non-fluence region having the zero-fluence region therebetween. The radiation method includes a first radiating step including radiating the first non-zero fluence region, along with moving a first group of leaf pairs and moving a vertical jaw to shade the first group of leaf pairs, and a second radiating step including radiating the second non-zero fluence region, along with moving a second group of leaf pairs and withdrawing the vertical jaw to expose the second group of leaf pairs.Type: GrantFiled: June 6, 2019Date of Patent: January 5, 2021Assignee: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventor: Weiyuan Wang
-
Publication number: 20200291072Abstract: Disclosed is a new class of conjugated virus-like particles (VLPs). These conjugated VLPs bind a wide variety of tumors and comprise epitopes recognized by a prior T cell immune response already existing in a host. These epitopes are derived from pathogens or previous vaccinations (such as early childhood vaccines). This provokes the body's pre-existing cytotoxic immunity obtained through previous infection or previous childhood vaccination to be redirected to the tumor cells for the elimination of cancer, and form long-term anti-tumor immunity. The described conjugated VLPs are useful for tailoring a broad range of tumors towards a response from existing immunity circumventing the need to identify tumor antigens or generate tumor-specific immune responses.Type: ApplicationFiled: December 26, 2019Publication date: September 17, 2020Inventors: Joshua Weiyuan WANG, Nattha INGAVAT, Ken MATSUI
-
Publication number: 20200113996Abstract: This invention relates to chimeric virus-like particles (VLPs) assembled from a polypeptide comprising a papilloma p virus (PV) L1 protein or L1/L2 protein and a target peptide comprising a CD8+ T cell epitope derived from a human pathogen. This invention also relates to methods using the chimeric VLPs as antigen-specific redirectors of immune responses.Type: ApplicationFiled: June 21, 2018Publication date: April 16, 2020Inventors: Joshua Weiyuan WANG, Nattha INGAVAT
-
Publication number: 20200023199Abstract: A method for irradiation based on a fluence map includes determining a shield type of each row of a fluence map. The method also includes determining, for each of the two rows, a movement curve indicating a relationship between an irradiation dose in the each of the two rows and a moving position of a leaf pair corresponding to the each of the two rows. The method further includes determining an initial irradiation dose for each of the movement curves and synchronizing one of the movement curves based on the shield types of the two rows. The method also includes selecting at least one irradiation dose of at least one point on an irradiation dose axis and generating a control point according to the selected irradiation dose.Type: ApplicationFiled: September 30, 2019Publication date: January 23, 2020Applicant: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventor: Weiyuan WANG
-
Publication number: 20190329068Abstract: The present disclosure provides a radiation method for radiating a fluence map having a zero-fluence region under a movement of MLC (Multi-Leaf Collimator) includes a determining step of determining at least one basic fluence map from the fluence map. The basic fluence map includes a first non-zero fluence region and a second non-fluence region having the zero-fluence region therebetween. The radiation method includes a first radiating step including radiating the first non-zero fluence region, along with moving a first group of leaf pairs and moving a vertical jaw to shade the first group of leaf pairs, and a second radiating step including radiating the second non-zero fluence region, along with moving a second group of leaf pairs and withdrawing the vertical jaw to expose the second group of leaf pairs.Type: ApplicationFiled: June 6, 2019Publication date: October 31, 2019Applicant: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventor: Weiyuan WANG
-
Patent number: 10434334Abstract: A method for irradiation based on a fluence map includes determining a shield type of each of a plurality of rows of a fluence map. The method also includes determining, for each of the plurality of rows, a movement curve indicating a relationship between an irradiation dose in the each of the plurality of rows and a moving position of a leaf pair corresponding to the each of the plurality of rows. The method further includes determining an initial irradiation dose for each of the movement curves and synchronizing one of the movement curves based on the shield types of the plurality of rows. The method also includes selecting at least one irradiation dose of at least one point on an irradiation dose axis and generating a control point according to the selected irradiation dose.Type: GrantFiled: December 30, 2016Date of Patent: October 8, 2019Assignee: SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.Inventor: Weiyuan Wang